~13yrs of neoadjuvant adventure comes to positive conclusion (for now)! In NEJM today & presented at #ASCO25 5 yr survival for pts w lung cancer that can be removed by surgery is better with just 3 doses of immunotherapy before the operation! nejm.org/doi/full/10.10… #LCSM 1/

We are pleased to announce that Dr. Andrei Brateanu has been officially selected as our Program Director for the IMRP! He has been serving as interim PD until now, and we are so excited to continue working with him! 🎉 #IMRP #GME #MedEd

Two studies investigating efficacy of bispecific T-cell engager tarlatamab and lurbinectedin–atezolizumab combination met their primary endpoints of survival. Read the opinion by Alfredo Addeo MD in the #ESMODailyReporter 🔗 ow.ly/Qp9N50W8j2m #SCLC #LungCancer

Before and After. Just 8 weeks. Nope, not lymphoma. THIS is non-small cell lung cancer. THIS is why molecular profiling matters. THIS is why targeted therapy changes lives.

A link to download the Editorial of the Year is now available. QuadShot News sciencedirect.com/science/articl…

Olé! IASLC World Lung 🫁 Conference is in Barcelona, 🇪🇸 this year: Sept 6-9. Excited to present our work on this global stage Sylvester Comprehensive Cancer Center

💥Immune checkpoint inhibitors save lives—but can wreak havoc on the gut. Learn how to recognize, work up, and treat immune-related diarrhea & colitis 💊🦠 Clear, practical guidance for medicine, onc & GI teams. 📄 bit.ly/ICIDIARRHEA #MedTwitter #Oncology #GI

🎉 Big news for Android users: OncLive Insider is officially on Google Play! Get personalized expert-driven oncology news, insights, and updates—accessible anytime, anywhere. 📲 Download now and stay connected to the latest in cancer care: hubs.li/Q03vGD-Z0

Eat Chocolate 🍫 a reminder from 2012 ⁦NEJM⁩ study nejm.org/doi/full/10.10…

Welcome to all our new fellows Sylvester Comprehensive Cancer Center ! 🎉Dan Morgenstern, MD, MSc Asad Rauf Valentina Ardila Jose Ferero and Derek Essegian We’re thrilled to have you join the team and look forward to working together. Here's to a great start and many shared successes ahead. welcome to the family!

Pericardiocentesis done perfectly by Chris in week one of fellowship! Shock resolved, patient stable, and Chris made it look easy. Big shoutout to Ran Lee, MD, FACC for the top-notch teaching and leadership while simultaneously attending on the unit! venu menon

☀️Breakfast this morning welcoming our Brand new Sylvester Comprehensive Cancer Center Miami Hem/Onc Program Director Hem-Onc Fellows Network #mentorshipmatters

Our first day of #HemeOnc Bootcamp wrapped up with a warm Jackson Health System clinic welcome for our new fellows—plus birthday celebrations to top it off! 🎉🎂 Once again, a big welcome to all our new fellows—we’re so excited to have you on board! 👏🎓gilberto lopes James Hoffman

The First Didactics of the New Academic Year – Miami Hematology Oncology Program Director Miami Hem/Onc Program Director Sylvester Comprehensive Cancer Center oncodaily.com/blog/miami-hem… #Cancer #CancerResearch #Medicine #Health #MedX #MedNews #MedEd #Hematology #Oncology #OncoDaily

Hot off the presses! Tips from the editorial board Journal of Clinical Oncology ASCO on what we're looking for in narrative medicine or poetry pieces for the Journal of Clinical Oncology! The Art of the Art of Oncology | Stephanie Graff, MD, FACP, FASCO Sylvester Comprehensive Cancer Center UMiami Health System ascopubs.org/doi/10.1200/JC…

Read about study presented by our chief fellow Chinmay Jani on alcohol and cancer The ASCO Post gilberto lopes Sylvester Comprehensive Cancer Center Dr. Estela Rodriguez

Why UM/Jackson is an incredible place to train for Hematology-Oncology fellowship: 🌟 NCI-Designated Cancer Center Sylvester Comprehensive Cancer Center with access to cutting-edge clinical trials and a highly diverse patient population 🩺 Fellows-run continuity clinic at Jackson Memorial where you

Our 2025-2026 #CMR group just wrapped up the 17th Annual Chief Resident Workshop—a 2-day #leadership conference with colleagues from Cleveland Clinic, University Hospitals, and MetroHealth where they dove into emotional intelligence, leadership styles, and team building! #MedEd #GME

We are proud to share that we are ranked among the Top 50 in the nation for cancer care by U.S. News & World Report! We’re also recognized as high performing in treating leukemia, lymphoma and myeloma conditions, as well as in surgery for colon, lung and prostate cancers. Read

"Give Cancer Hell." OHSU Knight Cancer Institute 2 pages in today's The New York Times.com Following a $2 billion gift from the Knights this week, the largest gift in US history